AlgiPharma AS
🏢 View company profile →11Patents
11Active
11Granted
48Portfolio score
Filing activity: Oct 24, 2008 → Aug 20, 2021 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8815831B2 | Treatment of Acinetobacter with alginate oligomers and antibiotics | Human Necessities | 10 | Active |
| US8680072B2 | Use of alginate oligomers in combating biofilms | Human Necessities | 9 | Active |
| US9877983B2 | Use of alginate oligomers in combating biofilms | Human Necessities | 3 | Active |
| US9018158B2 | Alginate oligomers for use in overcoming multidrug resistance in bacteria | Emerging Cross-Sectional Technologies | 1 | Active |
| US11712448B2 | Use of alginate oligomers as blood anticoagulants | Human Necessities | 0 | Active |
| US10624920B2 | Use of alginate oligomers in combating biofilms | Human Necessities | 0 | Active |
| US11992553B2 | Inhalable powder formulations of alginate oligomers | Human Necessities | 0 | Active |
| US10751363B2 | Use of aliginate oligomers and CFTR modulators in treatment of conditions associated with CFTR dysfunction | Human Necessities | 0 | Active |
| US11385174B2 | Method for the qualitative and quantitative detection of alginate oligomers in body fluids | Physics | 0 | Active |
| US11413306B2 | Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract | Human Necessities | 0 | Active |
| US9801901B2 | Alginate oligomers for use in overcoming multidrug resistance in bacteria | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.